The Food and Drug Administration (FDA) has approved Zepbound ® (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity.
Factors associated with higher odds of antiviral receipt include clinical influenza testing and ICU admission.
Black mothers are faced with a disproportionate number of barriers to breastfeeding compared to other racial and ethnic groups.
Dr. Renee Wynn is a doctorally educated, board-certified Women's Health Nurse Practitioner who focuses on perinatal and reproductive health justice. She is an Assistant Professor ...
As long as a drug shortage is declared, compounding pharmacies are still eligible to produce their own versions of Zepbound/Mounjaro. HealthDay News — The US Food and Drug Administration re ...
The Food and Drug Administration (FDA) has approved Steqeyma ® (ustekinumab-stba), a biosimilar to Stelara ® (ustekinumab), for the treatment of various chronic inflammatory diseases in adults and ...
At least 61 human bird flu cases have been diagnosed in the United States this year, but this is the first requiring hospitalization. HealthDay News — In a case first reported in Louisiana last ...
Vitamin D supplementation, with or without calcium, offers no benefit for preventing falls or fractures in community-dwelling seniors and may increase risk of kidney stones. HealthDay News — The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback